Posted inNews Prevention Research Sexual Health
UK DoxyPEP study recruiting participants
A new study in the UK investigating the effect of DoxyPEP on the gut microbiome…
Posted inNews PrEP Prevention Research
Twice-yearly lenacapavir 89% more effective than Truvada
New data from the PURPOSE 2 study shows that twice-yearly lenacapavir is 89% more effective…
Posted inConferences News Research Treatment
HIV viral rebounds following CRISPR gene therapy
EBT-101, a gene-editing therapy utilising CRISPR technology, showed promising safety and tolerability in an initial…